Alto Neuroscience Inc. (ANRO) is a publicly traded Healthcare sector company. As of October 19, 2026, ANRO trades at $23.29 with a market cap of $860.97M and a P/E ratio of -9.52. ANRO moved +5.88% today. Year to date, ANRO is +23.26%; over the trailing twelve months it is +273.13%. Its 52-week range spans $1.60 to $37.48. Analyst consensus is strong buy with an average price target of $44.00. Rallies surfaces ANRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ANRO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $23.29 |
| Market Cap | $860.97M |
| P/E Ratio | -9.52 |
| EPS | $-2.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $37.48 |
| 52-Week Low | $1.60 |
| Volume | 194.88K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-61.43M |
| Gross Margin | 0.00% |
5 analysts cover ANRO: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.00.